Biocomposites to host industry symposium and present new STIMULAN® data at EBJIS-MSIS 2026
- Industry symposium to explore local delivery of combination antibiotics across spine and arthroplasty
- Poster showcases the efficacy of STIMULAN® calcium sulfate beads, loaded with a combination of Gram-positive and Gram-negative antibiotics, against S. aureus biofilms
Keele, UK, 9 September 2026 – Biocomposites, an international medical devices company that engineers, manufactures and markets world-leading products for use in infection management in bone and soft tissue, today announces its participation as a Platinum Sponsor of the 44th Annual Meeting of the European Bone & Joint Infection Society (EBJIS) – in cooperation with the Musculoskeletal Infection Society (MSIS), taking place in Porto, Portugal, from 17–19 September 2026.
